BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17485552)

  • 21. Downregulated long non-coding RNA LINC00899 inhibits invasion and migration of spinal ependymoma cells via RBL2-dependent FoxO pathway.
    Chen QB; Li ZH; Fu Y; Lv NN; Tian N; Han L; Tian Y
    Cell Cycle; 2019 Oct; 18(19):2566-2579. PubMed ID: 31432742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RBL2 bi-allelic truncating variants cause severe motor and cognitive impairment without evidence for abnormalities in DNA methylation or telomeric function.
    Samra N; Toubiana S; Yttervik H; Tzur-Gilat A; Morani I; Itzkovich C; Giladi L; Abu Jabal K; Cao JZ; Godley LA; Mory A; Baris Feldman H; Tveten K; Selig S; Weiss K
    J Hum Genet; 2021 Nov; 66(11):1101-1112. PubMed ID: 33980986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The tumor suppressor Rb and its related Rbl2 genes are regulated by Utx histone demethylase.
    Terashima M; Ishimura A; Yoshida M; Suzuki Y; Sugano S; Suzuki T
    Biochem Biophys Res Commun; 2010 Aug; 399(2):238-44. PubMed ID: 20650264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene profiling approaches help to define the specific functions of retinoblastoma family in epidermis.
    Lara MF; García-Escudero R; Ruiz S; Santos M; Moral M; Martínez-Cruz AB; Segrelles C; Lorz C; Paramio JM
    Mol Carcinog; 2008 Mar; 47(3):209-21. PubMed ID: 17932948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alteration of microRNAs regulated by c-Myc in Burkitt lymphoma.
    Onnis A; De Falco G; Antonicelli G; Onorati M; Bellan C; Sherman O; Sayed S; Leoncini L
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20930934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential IgM expression distinguishes two types of pediatric Burkitt lymphoma in mouse and human.
    Eason AB; Sin SH; Lin C; Damania B; Park S; Fedoriw Y; Bacchi CE; Dittmer DP
    Oncotarget; 2016 Sep; 7(39):63504-63513. PubMed ID: 27566574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Orbital nodular fasciitis in child with biallelic germline RBL2 variant.
    Rips J; Abu-Libdeh B; Koplewitz BZ; Kehat-Ophir S; Frenkel S; Elpeleg O; Harel T
    Eur J Med Genet; 2022 Jun; 65(6):104513. PubMed ID: 35487417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53.
    Lindström MS; Klangby U; Wiman KG
    Oncogene; 2001 Apr; 20(17):2171-7. PubMed ID: 11360201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolutionarily conserved multisubunit RBL2/p130 and E2F4 protein complex represses human cell cycle-dependent genes in quiescence.
    Litovchick L; Sadasivam S; Florens L; Zhu X; Swanson SK; Velmurugan S; Chen R; Washburn MP; Liu XS; DeCaprio JA
    Mol Cell; 2007 May; 26(4):539-51. PubMed ID: 17531812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein arginine methyltransferase 5 suppresses the transcription of the RB family of tumor suppressors in leukemia and lymphoma cells.
    Wang L; Pal S; Sif S
    Mol Cell Biol; 2008 Oct; 28(20):6262-77. PubMed ID: 18694959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma.
    Lenze D; Leoncini L; Hummel M; Volinia S; Liu CG; Amato T; De Falco G; Githanga J; Horn H; Nyagol J; Ott G; Palatini J; Pfreundschuh M; Rogena E; Rosenwald A; Siebert R; Croce CM; Stein H
    Leukemia; 2011 Dec; 25(12):1869-1876. PubMed ID: 21701491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression.
    Leucci E; Onnis A; Cocco M; De Falco G; Imperatore F; Giuseppina A; Costanzo V; Cerino G; Mannucci S; Cantisani R; Nyagol J; Mwanda W; Iriso R; Owang M; Schurfeld K; Bellan C; Lazzi S; Leoncini L
    Int J Cancer; 2010 Mar; 126(6):1316-26. PubMed ID: 19530237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation.
    Leucci E; Cocco M; Onnis A; De Falco G; van Cleef P; Bellan C; van Rijk A; Nyagol J; Byakika B; Lazzi S; Tosi P; van Krieken H; Leoncini L
    J Pathol; 2008 Dec; 216(4):440-50. PubMed ID: 18802929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinoic acid induces persistent, RARalpha-mediated anti-proliferative responses in Epstein-Barr virus-immortalized b lymphoblasts carrying an activated C-MYC oncogene but not in Burkitt's lymphoma cell lines.
    Cariati R; Zancai P; Quaia M; Cutrona G; Giannini F; Rizzo S; Boiocchi M; Dolcetti R
    Int J Cancer; 2000 May; 86(3):375-84. PubMed ID: 10760826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sporadic and endemic Burkitt lymphoma have frequent
    Zhou P; Blain AE; Newman AM; Zaka M; Chagaluka G; Adlar FR; Offor UT; Broadbent C; Chaytor L; Whitehead A; Hall A; O'Connor H; Van Noorden S; Lampert I; Bailey S; Molyneux E; Bacon CM; Bomken S; Rand V
    Blood Adv; 2019 Jul; 3(14):2118-2127. PubMed ID: 31300419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma.
    Guan H; Xie L; Leithäuser F; Flossbach L; Möller P; Wirth T; Ushmorov A
    Blood; 2010 Sep; 116(9):1469-78. PubMed ID: 20519630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-17-5p enhances pancreatic cancer proliferation by altering cell cycle profiles via disruption of RBL2/E2F4-repressing complexes.
    Zhu Y; Gu J; Li Y; Peng C; Shi M; Wang X; Wei G; Ge O; Wang D; Zhang B; Wu J; Zhong Y; Shen B; Chen H
    Cancer Lett; 2018 Jan; 412():59-68. PubMed ID: 28987387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biallelic loss-of-function variants in RBL2 in siblings with a neurodevelopmental disorder.
    Brunet T; Radivojkov-Blagojevic M; Lichtner P; Kraus V; Meitinger T; Wagner M
    Ann Clin Transl Neurol; 2020 Mar; 7(3):390-396. PubMed ID: 32105419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RBL2/DREAM-mediated repression of the Aurora kinase A/B pathway determines therapy responsiveness and outcome in p53 WT NSCLC.
    Duan L; Perez RE; Calhoun S; Maki CG
    Sci Rep; 2022 Jan; 12(1):1049. PubMed ID: 35058503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and pathological features of Burkitt lymphoma showing expression of BCL2--an analysis including gene expression in formalin-fixed paraffin-embedded tissue.
    Masqué-Soler N; Szczepanowski M; Kohler CW; Aukema SM; Nagel I; Richter J; Siebert R; Spang R; Burkhardt B; Klapper W
    Br J Haematol; 2015 Nov; 171(4):501-8. PubMed ID: 26218299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.